Status:

RECRUITING

Refractory Breathlessness in COPD

Lead Sponsor:

Seoul National University

Conditions:

COPD

Eligibility:

All Genders

18-100 years

Brief Summary

This study aims to investigate the prognosis and clinical outcomes of patients with chronic obstructive pulmonary disease (COPD) who continue to experience refractory dyspnea despite treatment with lo...

Detailed Description

The study aims to identify actionable clinical factors and develop predictive models that can enhance personalized management approaches for patients with refractory dyspnea in COPD. This is a prospe...

Eligibility Criteria

Inclusion

  • Adults (≥ 18 years) diagnosed with chronic obstructive pulmonary disease (COPD) according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2025 criteria:
  • Presence of COPD risk factors (e.g., smoking history, occupational exposure, genetic predisposition).
  • Typical symptoms such as dyspnea, cough, or sputum production.
  • Post-bronchodilator FEV1/FVC \< 0.70.
  • Regular outpatient follow-up at the respiratory clinic.
  • Received LABA/LAMA combination therapy for at least 3 months prior to enrollment.
  • Ability and willingness to provide written informed consent.

Exclusion

  • Poor adherence to LABA/LAMA therapy (medication possession rate \< 50%) or refusal of treatment.
  • Inability or unwillingness to comply with scheduled visits, examinations, or follow-up procedures.
  • Presence of severe comorbid conditions expected to significantly affect prognosis, including:
  • End-stage diseases with life expectancy \< 1 year.
  • Terminal malignancies receiving hospice or palliative care.
  • Any condition that, in the opinion of the investigator, would interfere with study participation or data reliability.

Key Trial Info

Start Date :

April 11 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2031

Estimated Enrollment :

730 Patients enrolled

Trial Details

Trial ID

NCT07160322

Start Date

April 11 2024

End Date

December 31 2031

Last Update

September 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center

Seoul, Seoul, South Korea, 07061